Effects of Xal-Ease on Patient Compliance With Xalatan

Augusta University

Status: Unknown

Conditions: Glaucoma

Treatments: Device: Xal-Ease device to be used with Xalatan eye drops

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT00573638

05-02-266

Guarantor or CPI # 002533552

Details and patient eligibility

About

The study hypothesis is that the Xal-Ease with increase patient compliance with XALATAN

Enrollment: 50 estimated patients

Sex: All

Ages: 40 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 40 to 80 years old
• Diagnosis warranting treatment with Xalatan eye drops.
• ambulatory and well functioning

Exclusion criteria

• non-ambulatory
• less than 40 or greater than 80 years old
• Not using Xalatan eye drops

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)